首页 | 本学科首页   官方微博 | 高级检索  
检索        

大剂量短疗程血脂康治疗非酒精性脂肪肝疗效分析
引用本文:李世华,李丽萍,马洪涛,郭培英,吴一峰,陈金良.大剂量短疗程血脂康治疗非酒精性脂肪肝疗效分析[J].河北医药,2006,28(6):464-465.
作者姓名:李世华  李丽萍  马洪涛  郭培英  吴一峰  陈金良
作者单位:[1]邯郸铁路医院内科,河北省邯郸市056001 [2]河北工程大学附属医院医技科,河北省邯郸市056001 [3]不详,河北省邯郸市056001
摘    要:目的探讨大剂量、短疗程血脂康对非酒精性脂防肝(nonalcoholic steatohpatitis,NASH)的疗效.方法对300例NASH给予口服血脂康胶囊,2.4 g/d(0.3 g/粒),每日2次口服,疗程为8周,比较治疗前后其肝脏声像图及血脂、生化检查的变化情况.结果治疗后患者血清总胆固醇(TC)、甘油三酯(TG)和低密度脂蛋白胆固醇(LDL-C)显著下降(P<0.01),高密度脂蛋白胆固醇(HDL-C)有所上升,超声检查肝脏的大小、实质回声、管道纹理等声像图较治疗前有明显变化(P<0.01),总有效率79.7%(P<0.01),治疗期间无明显不良反应.结论血脂康大剂量、短疗程治疗对非酒精性脂肪肝有明显疗效,无明显副作用,值得推广.

关 键 词:降血脂药  血脂康  血脂  非酒精性脂肪肝
收稿时间:2005-11-12
修稿时间:2005-11-12

Clinical efficacy of Xuezhikang in the treatement of nonslcoholic steatohpatitis
LI Shihua,LI Liping,MA Hongtao ,et al..Clinical efficacy of Xuezhikang in the treatement of nonslcoholic steatohpatitis[J].Hebei Medical Journal,2006,28(6):464-465.
Authors:LI Shihua  LI Liping  MA Hongtao  
Institution:Department of Internal Medicine, Handan Railway Hospital, Hebei , Handan 056001
Abstract:Objective To observe the efficacy of Xuezhikang in the treatment of nonalcoholic steatohpatitis(NASH).Methods 300 patients with NASH were treated by Xuezhikang capsule 2.4 g daily for 8 weeks.(Echocardiography) of liver and lipid levels before and after treatment were measured and analysed.Results At the end of treatment,the clinical symptom,and the level of serum TC,TG and LDL-C were significantly decreased in the group(P<0.05).The parametes of ultrasound of liver changed significantly(P<0.0l).The total effective rate was(79.7%)(P<0.05).Conclusion Xuezhikang with high-dose and shorter treatment course is effective in treating NASH.
Keywords:antilipemic agents  Xuezhikang  blood lipid  nonalcoholic steatohpatitis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号